OCGN Stock: 5 Things Investors Need to Know Because Ocugen Grows 100% +

Occugen (NASDAQ:OCGN) The stock continues to rise on Wednesday, after yesterday’s news that it is helping to develop a vaccine for the new coronavirus.

A close-up of someone's eye

Source: Shutterstock

Yesterday’s news revealed that the company is working with Bharat Biotech to bring its coronavirus vaccine to the US. It will have the development and commercialization of OCGN in the country. Analyst Roth Zegbeh Jallah believes this will be a powerful source of funding and revenue for the company.

Adding to Ocugen’s positive news on Tuesday, the company also unveiled plans to postpone its annual shareholders’ meeting until Jan. 13, 2021. This will allow OCGN’s shareholders more time to vote on its growth plan. actions. The company intended to increase the shares by 500,000, but a new amendment seeks to reduce it to 400,000 shares.

Given all this news from Ocugen, several investors are interested in the company. As a result, more than 202 million shares of the stock changed this morning. This represents a major increase over the average daily trading volume of 19.25 million shares.

With all this in mind, let’s dive deeper into Ocugen with a breakdown of the company.

  • Ocugen is a biopharmaceutical company with a focus on the development of blinding treatments.
  • His current conduct includes three treatments for various forms of blindness.
  • The first is OCU400 and is developed to treat inherited retinal disorders.
  • OCU410 is its treatment for dry age-related macular degeneration and OCU200 is for neovascular disorders.
  • All of these treatments are still in the pre-clinical stage, but OCU400 is close to reaching phase 1 studies.

OCGN’s stock has risen 183% since Wednesday morning and has risen 344% since the beginning of the year.

At the time of publication, William White did not hold (directly or indirectly) any position in the securities referred to in this article.

Printed article from InvestorPlace Media, https://investorplace.com/2020/12/ocgn-stock-5-things-for-investors-to-know-as-ocugen-soars-100/.

© 2020 InvestorPlace Media, LLC